Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Blumenthal

Showing results (521-530 of 650) with videos related to

Pageof 65
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 28, 2018
Utilization of stress testing for low-risk patients with chest discomfort in the emergency departmentSheela Krishnan, Rachael Venn, Daniel M Blumenthal, et al.
The Oncologist|March 13, 2020
An Analysis of Recent FDA Oncology Scientific PublicationsJulie A Schneider, Andrew C Miklos, James Onken, et al.
JAMA Oncology|June 16, 2017
Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non-Small Cell Lung Cancer Trials: A Meta-analysisGideon M Blumenthal, Lijun Zhang, Hui Zhang, et al.
Plos One|March 1, 2019
Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancerTristan M Sissung, Arun Rajan, Gideon M Blumenthal, et al.
Clinical Trials (London, England)|March 19, 2019
Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directionsBellinda L King-Kallimanis, Lynn J Howie, Jessica K Roydhouse, et al.
Environmental Health Perspectives|October 1, 1987
Second chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1984 and by the National Toxicology Program through May 1986L S Gold, T H Slone, G M Backman, et al.
Nucleic Acids Research|April 20, 2021
Preferential CEBP binding to T:G mismatches and increased C-to-T human somatic mutationsJie Yang, John R Horton, Kadir C Akdemir, et al.
The Journal of Biological Chemistry|February 21, 2022
Enzymatic characterization of mRNA cap adenosine-N6 methyltransferase PCIF1 activity on uncapped RNAsDan Yu, Nan Dai, Eric J Wolf, et al.
The New Phytologist|September 17, 2013
Invasive forb benefits from water savings by native plants and carbon fertilization under elevated CO2 and warmingDana M Blumenthal, Víctor Resco, Jack A Morgan, et al.
Clinical Pharmacology and Therapeutics|February 14, 2015
The role of nonrandomized trials in the evaluation of oncology drugsR Simon, G M Blumenthal, M L Rothenberg, et al.
Pageof 65

Showing results (521-530 of 650) with videos related to

Sort By:
Pageof 65
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 28, 2018
Utilization of stress testing for low-risk patients with chest discomfort in the emergency departmentSheela Krishnan, Rachael Venn, Daniel M Blumenthal, et al.
The Oncologist|March 13, 2020
An Analysis of Recent FDA Oncology Scientific PublicationsJulie A Schneider, Andrew C Miklos, James Onken, et al.
JAMA Oncology|June 16, 2017
Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non-Small Cell Lung Cancer Trials: A Meta-analysisGideon M Blumenthal, Lijun Zhang, Hui Zhang, et al.
Plos One|March 1, 2019
Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancerTristan M Sissung, Arun Rajan, Gideon M Blumenthal, et al.
Clinical Trials (London, England)|March 19, 2019
Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directionsBellinda L King-Kallimanis, Lynn J Howie, Jessica K Roydhouse, et al.
Environmental Health Perspectives|October 1, 1987
Second chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1984 and by the National Toxicology Program through May 1986L S Gold, T H Slone, G M Backman, et al.
Nucleic Acids Research|April 20, 2021
Preferential CEBP binding to T:G mismatches and increased C-to-T human somatic mutationsJie Yang, John R Horton, Kadir C Akdemir, et al.
The Journal of Biological Chemistry|February 21, 2022
Enzymatic characterization of mRNA cap adenosine-N6 methyltransferase PCIF1 activity on uncapped RNAsDan Yu, Nan Dai, Eric J Wolf, et al.
The New Phytologist|September 17, 2013
Invasive forb benefits from water savings by native plants and carbon fertilization under elevated CO2 and warmingDana M Blumenthal, Víctor Resco, Jack A Morgan, et al.
Clinical Pharmacology and Therapeutics|February 14, 2015
The role of nonrandomized trials in the evaluation of oncology drugsR Simon, G M Blumenthal, M L Rothenberg, et al.
Pageof 65